The role of renin-angiotensin system in prothrombotic state in essential hypertension. A Remková, M Remko Physiological Research 59 (1), 2010 | 103 | 2010 |
Impact of the therapy by renin–angiotensin system targeting antihypertensive agents perindopril versus telmisartan on prothrombotic state in essential hypertension A Remková, H Kratochvil'ova, J Ďurina Journal of human hypertension 22 (5), 338-345, 2008 | 66 | 2008 |
Thrombomodulin as a marker of endothelium damage in some clinical conditions A Remková, E Kováčová, M Prı́kazská, H Kratochvı́l’ová European Journal of Internal Medicine 11 (2), 79-84, 2000 | 49 | 2000 |
Homocysteine and endothelial markers are increased in patients with chronic liver diseases A Remková, M Remko European Journal of Internal Medicine 20 (5), 482-486, 2009 | 36 | 2009 |
A Comparative Study of Molecular Structure, pKa, Lipophilicity, Solubility, Absorption and Polar Surface Area of Some Antiplatelet Drugs M Remko, A Remková, R Broer International journal of molecular sciences 17 (3), 388, 2016 | 35 | 2016 |
Effect of the new centrally acting antihypertensive agent rilmenidine on endothelial and platelet function in essential hypertension A Remkova, H Kratochvil'ova Journal of human hypertension 16 (8), 549-555, 2002 | 34 | 2002 |
Effect of the angiotensin-converting enzyme inhibitor perindopril on haemostasis in essential hypertension A Remková, H Kratochvil'ova Blood coagulation & fibrinolysis 11 (7), 641-644, 2000 | 31 | 2000 |
Platelet abnormalities in chronic thromboembolic pulmonary hypertension A Remková, I Šimková, T Valkovičová International journal of clinical and experimental medicine 8 (6), 9700, 2015 | 27 | 2015 |
A comparative study of the molecular structure, lipophilicity, solubility, acidity, absorption and polar surface area of coumarinic anticoagulants and direct thrombin inhibitors M Remko, R Broer, A Remková RSC Advances 4 (16), 8072-8084, 2014 | 22 | 2014 |
Platelet abnormalities in adults with severe pulmonary arterial hypertension related to congenital heart defects (Eisenmenger syndrome) A Remková, I Šimková, T Valkovicová, M Kaldarárová Blood Coagulation & Fibrinolysis 27 (8), 925-929, 2016 | 21 | 2016 |
Diagnostic approach to hypercoagulable states A Remkova Bratislavske lekarske listy 107 (8), 292, 2006 | 21 | 2006 |
Molecular structure and acidity of captopril, zofenopril and their metabolites captopril disulfide and zofenoprilat M Remko, J Bojarska, A Remková, W Maniukiewicz Computational and Theoretical Chemistry 1062, 50-55, 2015 | 20 | 2015 |
Prothrombotic state in metabolic syndrome J Durina, A Remkova Bratisl Lek Listy 108 (6), 279-280, 2007 | 20 | 2007 |
Theoretical study of molecular structure and physicochemical properties of novel factor Xa inhibitors and dual factor Xa and factor IIa inhibitors M Remko, A Remková, R Broer Molecules 21 (2), 185, 2016 | 19 | 2016 |
General changes in hemostasis in gastric cancer E Kovacova, S Kinova, I Duris, A Remkova Bratisl Lek Listy 110 (4), 215-21, 2009 | 18 | 2009 |
B cell chronic lymphocytic leukemia with meningeal infiltration by T lymphocytes A Remková, T Bezayová, M Vyskočil European Journal of Internal Medicine 14 (1), 49-52, 2003 | 17 | 2003 |
Risk factors detection in chronic thromboembolic pulmonary hypertension, a tool for risk quantification? M Bohacekova, M Kaldararova, T Valkovicova, A Remkova, J Vesely, ... Bratislavske Lekarske Listy 117 (10), 577-582, 2016 | 16 | 2016 |
Serum transferrin receptor in diagnosis of iron deficiency M Simek, A Remkova, H Kratochvilova Bratislavske lekarske listy 103 (12), 449-453, 2002 | 11 | 2002 |
Acute vasculitis as a first manifestation of hairy cell leukemia A Remková, A Halčín, E Šteňová, P Babál, V Kasperová, A Vranovský European Journal of Internal Medicine 18 (3), 238-240, 2007 | 10 | 2007 |
Pulmonary thromboembolism in congenital heart defects with severe pulmonary arterial hypertension M Kaldararova, I Simkova, T Valkovicova, A Remkova, V Neuschl Cor et Vasa 55 (2), e170-e175, 2013 | 6 | 2013 |